Discover the passion, experience, and vision behind our success
We are a team working behind the scenes that is dedicated to supporting entrepreneurs and their companies.
Vigilance Leadership Team
Read bio
AI and biotech executive with experience spanning the private sector, government, and academia. Previously served as the first head of biotech strategy at the U.S. Department of Defense and held VP-level AI roles at Avidity Biosciences and Colossal Biosciences.
At Alloy, Titus serves as CEO of Vigilance, focused on ensuring critical capabilities and countermeasures are available when needed most.
Read bio
Biosecurity and technology policy executive with a career spanning government, scientific publishing, and international affairs. Previously served as Chief of Staff and inaugural Director for International Affairs at ARPA-H, and held senior roles at the U.S. Department of State and the White House National Security Council.
At Alloy, Megan serves as Chief Strategy Officer of Vigilance, focused on strengthening U.S. biotechnology competitiveness, leadership, and health security.
Read bio
Biosecurity and health security executive with expertise spanning policy, diplomacy, and nearly 15 years of experience in virology and immunology, including preclinical therapeutic development for high-consequence pathogens. Previously served as Director for Biotechnology Risks and Biological Weapons Nonproliferation at the White House National Security Council and held senior roles at the U.S. Department of State and IBBIS.
At Alloy, Kirsten serves as Chief Science and Technology Officer of Vigilance, focused on biosecurity and rapid response to emerging biological threats.
Read bio
Biotech operations executive with nearly a decade of experience supporting senior R&D and commercial leaders across the industry. Previously held executive operations roles at Avidity Biosciences, Soleno Therapeutics, and Eikon Therapeutics, including serving as executive assistant to the Chief Scientific Officer.
At Alloy, Alexandra serves as Chief of Staff for Vigilance, driving strategy, operations, and execution alongside the CEO.
Read bio
Data science and AI strategy executive with more than a decade of experience in the life sciences. Previously founded and led the data science function at Horizon Therapeutics, continued that work at Amgen following its acquisition, and served as data science and AI lead for Avidity Biosciences’ commercial launch.
At Alloy, Karl serves as Chief AI Officer for Vigilance, leading responsible AI innovation across the organization.